Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,065 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improvement in Risk Stratification in Transcatheter Aortic Valve Implantation Using a Combination of the Tumor Marker CA125 and the Logistic EuroSCORE.
Husser O, Núñez J, Burgdorf C, Holzamer A, Templin C, Kessler T, Bodi V, Sanchis J, Pellegrini C, Luchner A, Maier LS, Schmid C, Lüscher TF, Schunkert H, Kastrati A, Hilker M, Hengstenberg C. Husser O, et al. Among authors: pellegrini c. Rev Esp Cardiol (Engl Ed). 2017 Mar;70(3):186-193. doi: 10.1016/j.rec.2016.08.004. Epub 2016 Sep 9. Rev Esp Cardiol (Engl Ed). 2017. PMID: 27623490 English, Spanish.
Multicenter Comparison of Novel Self-Expanding Versus Balloon-Expandable Transcatheter Heart Valves.
Husser O, Kim WK, Pellegrini C, Holzamer A, Walther T, Mayr PN, Joner M, Kasel AM, Trenkwalder T, Michel J, Rheude T, Kastrati A, Schunkert H, Burgdorf C, Hilker M, Möllmann H, Hengstenberg C. Husser O, et al. Among authors: pellegrini c. JACC Cardiovasc Interv. 2017 Oct 23;10(20):2078-2087. doi: 10.1016/j.jcin.2017.06.026. JACC Cardiovasc Interv. 2017. PMID: 29050625 Free article.
Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: A two-center experience of incidence, outcome and temporal trends from 2010 to 2015.
Trenkwalder T, Pellegrini C, Holzamer A, Philipp A, Rheude T, Michel J, Reinhard W, Joner M, Kasel AM, Kastrati A, Schunkert H, Endemann D, Debl K, Mayr NP, Hilker M, Hengstenberg C, Husser O. Trenkwalder T, et al. Among authors: pellegrini c. Catheter Cardiovasc Interv. 2018 Jul;92(1):149-156. doi: 10.1002/ccd.27385. Epub 2017 Nov 11. Catheter Cardiovasc Interv. 2018. PMID: 29130616
Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve implantation.
Rheude T, Pellegrini C, Reinhard W, Trenkwalder T, Koenig W, Mayr NP, Joner M, Núñez J, Holdenrieder S, Schunkert H, Kastrati A, Hengstenberg C, Husser O. Rheude T, et al. Among authors: pellegrini c. Biomarkers. 2018 May;23(3):299-304. doi: 10.1080/1354750X.2018.1423706. Epub 2018 Jan 15. Biomarkers. 2018. PMID: 29297708
Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation.
Rheude T, Pellegrini C, Schmid H, Trenkwalder T, Mayr NP, Joner M, Kasel AM, Holdenrieder S, Nunez J, Sanchis J, Bodi V, Schunkert H, Kastrati A, Hengstenberg C, Husser O. Rheude T, et al. Among authors: pellegrini c. Am J Cardiol. 2018 Feb 15;121(4):461-468. doi: 10.1016/j.amjcard.2017.11.020. Epub 2017 Nov 27. Am J Cardiol. 2018. PMID: 29306485
1,065 results